Qing Sarah Yuan
Technik-/Wissenschafts-/F&E-Leiter bei SIGILON THERAPEUTICS, INC.
Profil
Qing Sarah Yuan is currently the Chief Technical Operations Officer at Sigilon Therapeutics, Inc. Prior to this, she worked as the Head-Technical Development at Bioverativ, Inc. from 2017 to 2019.
She also held the position of Vice President-Process & Analytical Development at 2seventy Bio, Inc. Dr. Yuan holds a doctorate degree from the University of Wisconsin and an undergraduate degree from the University of California, Berkeley.
Aktive Positionen von Qing Sarah Yuan
| Unternehmen | Position | Beginn |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.03.2022 |
Ehemalige bekannte Positionen von Qing Sarah Yuan
| Unternehmen | Position | Ende |
|---|---|---|
| BIOVERATIV INC | Corporate Officer/Principal | 01.01.2019 |
| 2SEVENTY BIO, INC. | Corporate Officer/Principal | - |
Ausbildung von Qing Sarah Yuan
| University of Wisconsin | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
